ArticleBioinformatics (Oxford, England)2026
Enhancing cross-context generalization in drug perturbation prediction with a multimodal conditional diffusion framework.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
motivationPredicting drug-induced transcriptional perturbations is critical for precision medicine, yet existing models fail to capture multimodal biological context, limiting generalization across unseen drugs and cell lines.
resultsWe present PertDiff, a conditional diffusion framework that integrates control gene expression, LLM-derived cell semantics, and pretrained molecular graph representations to predict transcriptome-wide perturbations. PertDiff outperforms state-of-the-art baselines in prediction accuracy and generalizes robustly across drugs and cell lines. It further demonstrates translational utility through accurate drug sensitivity prediction, therapeutic repurposing for pancreatic cancer, and concordance with real-world clinical treatment outcomes, establishing it as a biologically grounded transcriptomic modeling tool. AVAILABILITY: The source code and data are available at https://github.com/Panda-myj/PertDiff and https://doi.org/10.5281/zenodo.18427848.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.